Literature DB >> 11418144

NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection.

M Boers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11418144     DOI： 10.1016/S0140-6736(00)04451-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Selective COX-2 inhibitors: a health economic perspective.

Authors:  David L B Schwappach; Christian M Koeck
Journal:  Wien Med Wochenschr       Date:  2003

2.  Balancing benefits and harms in health care.

Authors:  Luis Gabriel Cuervo; Mike Clarke
Journal:  BMJ       Date:  2003-07-12

3.  Patient characteristics associated with prescribing of a newly introduced drug: the case of rofecoxib.

Authors:  Stefan R Florentinus; Merete W Nielsen; Liset van Dijk; Hubert G M Leufkens; Ebba Holme Hansen; Eibert R Heerdink
Journal:  Eur J Clin Pharmacol       Date:  2005-03-11       Impact factor: 2.953

Review 4.  Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone.

Authors:  Arrigo F G Cicero; Giuseppe Derosa; Antonio Gaddi
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Synthesis of 2-(N-Benzylpyrrolyl)-benzimidazoles Using Polyphosphoric Acid Prompted Cyclocondensation.

Authors:  Bereket Mochona; Laine Le; Madhavi Gangapuram; Nelly Mateeva; Tiffany Ardley; Kinfe K Redda
Journal:  J Heterocycl Chem       Date:  2010-11-01       Impact factor: 2.193

6.  Safety profile of rofecoxib as used in general practice in England: results of a prescription-event monitoring study.

Authors:  Deborah Layton; Jane Riley; Lynda V Wilton; Saad A W Shakir
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

Review 7.  Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.

Authors:  Michael T Nurmohamed; Vokko P van Halm; Ben A C Dijkmans
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Prescribing of gastroprotective drugs among elderly NSAID users in The Netherlands.

Authors:  K N van Dijk; K ter Huurne; C S de Vries; P B van den Berg; J R B J Brouwers; L T W de Jong-van den Berg
Journal:  Pharm World Sci       Date:  2002-06

9.  A clinical audit of the prescribing of celecoxib and rofecoxib in Australian rural general practice.

Authors:  Christopher Cutts; Adam LaCaze; Susan Tett
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

10.  Pharmacological Evaluation of Artemisia cina Crude CO2 Subcritical Extract after the Removal of Santonin by Means of High Speed Countercurrent Chromatography.

Authors:  Zuriyadda Sakipova; Thais Biondino Sardella Giorno; Tolkyn Bekezhanova; Nikki Siu Hai Wong; Alma Shukirbekova; Patricia Dias Fernandes; Fabio Boylan
Journal:  Molecules       Date:  2020-06-12       Impact factor: 4.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.